Orna Therapeutics Enhances Circular RNA Capabilities, Acquires ReNAgade Therapeutics

Image Credit: Adobe Stock Images/NateeMeepian.com Orna Therapeutics, a biotechnology company that strives to design new classes of fully engineered circular RNA therapeutics (oRNA), has acquired ReNAgade Therapeutics.1 The company’s goal is to a “unlock the potential of RNA therapeutics,” specifically pertaining to delivery that demonstrated to multiple extra-hepatic cells in non-human primate (NHP) models over […]

Continue Reading

Office Distress Risks Rising

The anticipated wave of office distress hasn’t fully materialized, but the latest CommercialEdge office report indicates many markets are at risk. Vacancy rates have surged as companies downsize or close physical offices. Image by Jeremy Poland/iStockphoto.com Debt service coverage ratios (DSCRs), measuring net operating income against debt obligations, have declined due to rising interest rates […]

Continue Reading

Jagsonpal Pharma introduces new product; shares rise

Jagsonpal Pharmaceuticals Ltd’s shares were up by 4.71 per cent after the company announced the launch of MemUp, a hormone replacement therapy (HRT) featuring a USFDA-approved combination of bioidentical estradiol and bioidentical progesterone in a single daily oral capsule. MemUp aims to address vasomotor symptoms of menopause, such as hot flashes, night sweats, and sleep issues.  […]

Continue Reading